EWA
ALNY icon

EP Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

EP Wealth Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$229K Buy
692
+21
+3% +$7.15K ﹤0.01% 1329
2025
Q4 		$267K Buy
+671
New +$297K ﹤0.01% 1202
2025
Q2 		$233K Sell
713
-285
-29% -$78.9K ﹤0.01% 1164
2025
Q1 		$269K Buy
+998
New +$256K ﹤0.01% 965
2024
Q4 		– Sell
-732
Closed -$201K – 1239
2024
Q3 		$201K Buy
+732
New +$191K ﹤0.01% 1045
2023
Q4 		– Sell
-1,177
Closed -$208K – 816
2023
Q3 		$208K Buy
1,177
+71
+6% +$13.5K ﹤0.01% 658
2023
Q2 		$225K Hold
1,106
– – ﹤0.01% 627
2023
Q1 		$222K Sell
1,106
-10
-0.9% -$2.1K ﹤0.01% 556
2022
Q4 		$265K Buy
+1,116
New +$238K ﹤0.01% 492

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return